Guidance matches osteoarthritis patients to NSAIDs according to risk of side effectsBMJ 2015; 350 doi: http://dx.doi.org/10.1136/bmj.h1501 (Published 19 March 2015) Cite this as: BMJ 2015;350:h1501
- Zosia Kmietowicz
- 1The BMJ
A multidisciplinary group of clinicians has advised which non-steroidal anti-inflammatory drugs (NSAIDs) are appropriate for patients with osteoarthritis, in line with the drugs’ risk of upper and lower gastrointestinal and cardiovascular side effects.
Despite the many guidelines on the use of NSAIDs none has looked specifically at the risks of these adverse effects, the authors wrote in BioMed Central Medicine.1 As nearly half of patients with osteoarthritis (44%) have …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial